Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-16-085454
Filing Date
2016-03-02
Accepted
2016-03-02 09:00:18
Documents
2
Period of Report
2016-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v432225_6k.htm 6-K 28224
2 GRAPHIC xtlbiologo.jpg GRAPHIC 3938
  Complete submission text file 0001144204-16-085454.txt   34803
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 161475675
SIC: 2834 Pharmaceutical Preparations